CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PATENTS ANALYSIS
3.4.1. Patent analysis by year
3.4.2. Patent analysis by region
3.5. PORTERS FIVE FORCES ANALYSIS
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Technological advancements associated with ALH systems
3.6.1.2. Availability of improved and error free ALH systems
3.6.1.3. Dearth of skilled professionals
3.6.2. Restraints
3.6.2.1. Laboratory budget constraints affects procurement of ALH systems
3.6.2.2. Complex operability of latest liquid handling systems
3.6.3. Opportunities
3.6.3.1. Untapped potential of emerging markets
3.6.3.2. Development of miniaturized ALH systems
CHAPTER 4 GLOBAL AUTOMATED LIQUID HANDLING MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size & forecast
4.2. STANDALONE
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.3. INDIVIDUAL BENCHTOP WORKSTATIONS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast
4.4. MULTI-INSTRUMENT
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast
4.5. OTHERS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size & forecast
CHAPTER 5 GLOBAL AUTOMATED LIQUID HANDLING MARKET, BY MODALITY
5.1. OVERVIEW
5.1.1. Market size & forecast
5.2. DISPOSABLE TIPS
5.2.1. Market size & forecast
5.3. FIXED TIPS
5.3.1. Market size & forecast
CHAPTER 6 GLOBAL AUTOMATED LIQUID HANDLING MARKET, BY PROCEDURE
6.1. OVERVIEW
6.1.1. Market size & forecast
6.2. SERIAL DILUTION
6.2.1. Market size & forecast
6.3. PLATE REFORMATTING
6.3.1. Market size & forecast
6.4. PLATE REPLICATION
6.4.1. Market size & forecast
6.5. PCR SETUP
6.5.1. Market size & forecast
6.6. HIGH THROUGHPUT SCREENING
6.6.1. Market size & forecast
6.7. CELL CULTURE
6.7.1. Market size & forecast
6.8. WHOLE GENOME AMPLIFICATION
6.8.1. Market size & forecast
6.9. ARRAY PRINTING
6.9.1. Market size & forecast
6.10. OTHERS
6.10.1. Market size & forecast
CHAPTER 7 GLOBAL AUTOMATED LIQUID HANDLING MARKET, BY END USERS
7.1. OVERVIEW
7.1.1. Market size & forecast
7.2. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
7.2.1. Market size & forecast
7.3. CONTRACT RESEARCH ORGANIZATIONS
7.3.1. Market size & forecast
7.4. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
7.4.1. Market size & forecast
CHAPTER 8 AUTOMATED LIQUID HANDLING MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size & forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size & forecast
8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size & forecast
8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Taiwan market size and forecast
8.4.3.7. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size & forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. Turkey market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. ILLUMINA, INC
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. THERMO FISHER SCIENTIFIC, INC
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. ABCAM PLC
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. EPIZYME, INC.
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. NEW ENGLAND BIOLABS, INC. (NEB)
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. QIAGEN N.V.,
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. MERCK & CO., (MERCK)
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. ACTIVE MOTIF
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. DIAGENODE, INC.
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. ZYMO RESEARCH CORPORATION (ZYMO)
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments